Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Benjamin Riche, Hélène Bricout, Marie-Laure Kürzinger, Sylvain Roche, Jean Iwaz, Jean-François Etard & René Ecochard. (2016) Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns. Expert Review of Vaccines 15:7, pages 927-936.
Read now
Read now
Armando Stefanati, Nicoletta Valente, Silvia Lupi, Sara Previato, Matilde Giordani & Giovanni Gabutti. (2015) Herpes zoster vaccination in the elderly subjects: improving awareness and uptake. Patient Intelligence 7, pages 15-20.
Read now
Read now
Mona Marin, Barbara P Yawn, Craig M Hales, Peter C Wollan, Stephanie R Bialek, John Zhang, Marge J Kurland & Rafael Harpaz. (2015) Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Human Vaccines & Immunotherapeutics 11:5, pages 1157-1164.
Read now
Read now
Luis Salleras, Montse Salleras, Patricia Salvador, Núria Soldevila, Andreu Prat, Patricio Garrido & Angela Domínguez. (2015) Herpes zoster and postherpetic neuralgia in Catalonia (Spain). Human Vaccines & Immunotherapeutics 11:1, pages 178-184.
Read now
Read now
Jamie S Massengill & John L Kittredge. (2014) Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider. Journal of Pain Research 7, pages 125-132.
Read now
Read now
María D Esteban-Vasallo, M Felicitas Domínguez-Berjón, Ruth Gil-Prieto, Jenaro Astray-Mochales & Ángel Gil de Miguel. (2014) Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster. Human Vaccines & Immunotherapeutics 10:6, pages 1650-1660.
Read now
Read now
Articles from other publishers (14)
Sharon G. Curhan, Kosuke Kawai, Barbara Yawn, Kathryn M. Rexrode, Eric B. Rimm & Gary C. Curhan. (2022) Herpes Zoster and Long‐Term Risk of Cardiovascular Disease. Journal of the American Heart Association 11:23.
Crossref
Crossref
Catherina X. Pan, Michelle S. Lee & Vinod E. Nambudiri. (2022) Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 10, pages 251513552210845.
Crossref
Crossref
Didier Schoevaerdts, François-Xavier Sibille & Gaetan Gavazzi. (2019) Infections in the older population: what do we know?. Aging Clinical and Experimental Research 33:3, pages 689-701.
Crossref
Crossref
J. Gaillat. (2020) Zona. Revue des Maladies Respiratoires Actualités 12, pages A17-A20.
Crossref
Crossref
Ursula Kunze & Ernest Groman. (2017) Impfen ist nicht nur Kindersache!Immunizing is not only a children’s matter!. Wiener Medizinische Wochenschrift 169:9-10, pages 203-214.
Crossref
Crossref
Risako Shirane, Huamin Tang, Kenichi Hayashi, Yoshinobu Okuno, Hiroyasu Iso, Hideo Asada, Koichi Yamanishi & Yasuko Mori. (2017) Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study. Journal of Medical Virology 89:2, pages 313-317.
Crossref
Crossref
Melanie Drolet. 2017. Herpes Zoster: Postherpetic Neuralgia and Other Complications. Herpes Zoster: Postherpetic Neuralgia and Other Complications
119
140
.
Ramya Kollipara, Christopher Downing, Jacqueline Guidry, Michael Lee, Natalia Mendoza, Cesar Arias, Andrew Peranteau & Stephen K. Tyring. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
289
312
.
Robert W. Johnson, Marie-José Alvarez-Pasquin, Marc Bijl, Elisabetta Franco, Jacques Gaillat, João G. Clara, Marc Labetoulle, Jean-Pierre Michel, Luigi Naldi, Luis S. Sanmarti & Thomas Weinke. (2015) Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Therapeutic Advances in Vaccines 3:4, pages 109-120.
Crossref
Crossref
Jean-Pierre Michel. (2015) Herpes zoster vaccine: a shot to maintain wellbeing. Aging Clinical and Experimental Research 27:1, pages 1-3.
Crossref
Crossref
J. Ruiz-Aragón, M. García-Cenoz, S. Márquez-Peláez & C. Navarro Palenzuela. (2014) Evaluación de la vacuna para la prevención del herpes zóster en adultos: revisión sistemática de la literatura. Vacunas 15:1-2, pages 13-20.
Crossref
Crossref
John W. GnannJr.Jr.. 2014. Viral Infections of Humans. Viral Infections of Humans
971
999
.
Nuria Morant-Talamante, Javier Diez-Domingo, Sergio Martínez-Úbeda, Joan Puig-Barberá, Sara Alemán-Sánchez & Lina Pérez-Breva. (2013) Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infectious Diseases 13:1.
Crossref
Crossref
Gillian M. Keating. (2013) Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review of Its Use in the Prevention of Herpes Zoster and Postherpetic Neuralgia in Adults Aged ≥50 Years. Drugs 73:11, pages 1227-1244.
Crossref
Crossref